GC62977
FR-229934
Also known as 3-[(3,4-dichlorophenyl)methyl]-2-methyl-N-pentylsulfonylbenzimidazole-5-carboxamide
FR-229934 is a PDE V inhibitor extracted from patent WO2019130052A1
ChemicalCAS799841-02-4MW468.4FormulaC21H23Cl2N3O3S
- CAS number
- 799841-02-4
- Molecular weight
- 468.4
- Formula
- C21H23Cl2N3O3S
- Solubility
- DMSO ： 100 mg/mL (213·49 mM; Need ultrasonic)
- InChIKey
- QLXVZAXTUBLQJW-UHFFFAOYSA-N
- Catalogue number
- GC62977
- Brand
- GLPBIO
Computed properties PubChem CID 11259905 · XLogP 5.3 · TPSA 89.4 Ų · H-bond donors 1
- XLogP
- 5.3
- TPSA
- 89.4 Ų
- H-bond donors
- 1
- H-bond acceptors
- 4
- Rotatable bonds
- 8
- Heavy atoms
- 30
SMILES CCCCCS(=O)(=O)NC(=O)C1=CC2=C(C=C1)N=C(N2CC3=CC(=C(C=C3)Cl)Cl)C
Computed descriptors from PubChem (CID 11259905), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il